Assembly committee hears bill to protect medication access for incarcerated and institutionalized Nevadans

The Assembly Government Affairs Committee on Tuesday opened a hearing on Assembly Bill 208, a measure sponsored by Assemblymember Steve Yeager that its backers said would protect “the continuity of care for vulnerable populations” by limiting substitution or cutoff of federally reviewed medications and medical devices used in state correctional and state-operated mental-health facilities.

Why it matters: Sponsors and supporters told the committee the bill aims to prevent people confined in state custody from losing access to medications and devices they rely on—examples raised included long-term heart medications, antipsychotics, hearing-aid batteries and other devices—and to provide a route for those items to be obtained outside a facility if coverage through Medicaid is cut off.

Assemblymember Steve Yeager, sponsor of AB208, told the committee the bill “has the goal of protecting the continuity of care for vulnerable populations,” and said a proposed conceptual amendment limits the measure’s reach to state correctional facilities, state-operated mental-health facilities and mental-health centers. Atar Hasibullah, executive director of the American Civil Liberties Union of Nevada, said the bill was designed in part to avoid repeated litigation and to provide practical recourse when medications are no longer accessible for people in institutional settings: “Our goal is straightforward here. At the ACLU, we hope to avoid having to litigate these issues long term.”

What the bill would do: As described by sponsors and staff in the hearing record, AB208 would define “federally reviewed products” and restrict use by covered government entities when that use is inconsistent with written directions, limitations or intended usage. The conceptual amendment discussed at the hearing narrows initial, broader language so the bill applies only to: state correctional facilities, state-operated mental-health facilities and mental-health centers (statutory references cited in the discussion included NRS 144 and NRS 433.233). Sponsors also said the amendment would permit facilities, where necessary, to help institutionalized individuals procure medications or devices from an outside licensed pharmacy or nonprofit provider if Medicaid coverage is no longer available.

Questions from lawmakers: Committee members pressed sponsors on enforcement, scope and unintended consequences. Assemblymember DeLong asked whether existing regulatory agencies could act faster than the Legislature; Hasibullah replied that complaints keep coming to the ACLU because, in his view, state oversight has not reliably addressed the problems raised. Assemblymember Karas asked how outside procurement would work; Hasibullah pointed to nonprofit providers that sometimes supply medications and said the conceptual amendment would let an individual work with the facility to obtain items from a third party. James Zurenda, director of the Nevada Department of Corrections, clarified that “Medicaid does not pick up our medications and the Department of Correction is actually against the law for Medicaid to cover those expenses unless it’s within the last 90 days of release,” and described the department’s use of a formulary and a review panel for non-formulary requests.

Concerns from medical groups and retailers: Leah Cartwright of the Nevada Psychiatric Association testified in opposition and said the amendment as drafted could be overly broad by covering outpatient clinics and mobile crisis teams; she cited propranolol as an example of a medication used off label in psychiatric practice and urged further narrowing. Brian Wachter of the Retail Association of Nevada testified in support, saying his members want products used as intended and that pharmacies generally follow standard practices for off-label uses.

Formal actions at the meeting: before the AB208 hearing the committee introduced BDR 36,393 (a separate BDR to revise permissions relating to artificial intelligence). Vice Chair Wynne moved to introduce the BDR; Assemblymember Flanagan seconded; the motion carried. The committee did not vote on AB208 at this hearing; sponsors said they would work with stakeholders on narrowing language and that agency rulemaking would follow if the bill is enacted.

Context and next steps: Sponsors and several committee members described AB208 as a narrow, interim step intended to protect people in state custody while the Legislature is not in session and to reduce the need for litigation. Multiple lawmakers and witnesses said implementation details, enforcement mechanisms and any monitoring or anti-retaliation protections were topics for further work. The committee received a mix of support, opposition and neutral testimony and left the bill at the hearing stage; sponsors asked members to contact them with technical questions and indicated willingness to refine the amendment.

Ending: The committee closed testimony and the hearing record for AB208; no floor or committee vote on the bill occurred during the session recorded in the transcript.